Dual pathway inhibition a new antithrombotic strategy for CAD and PAD
24 Jul 2020
byNatalia Reoutova
Dual pathway inhibition (DPI) is a new antithrombotic strategy in coronary artery disease (CAD) and peripheral artery disease (PAD), according to Professor Dominick Angiolillo from the University of Florida College of Medicine in Jacksonville, Florida, US, who discussed the latest updates and clinical implications of these treatment strategies at the 28th Annual Scientific Congress of the Hong Kong College of Cardiology.
